Literature DB >> 8673483

Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression.

N A Losseff1, S L Webb, J I O'Riordan, R Page, L Wang, G J Barker, P S Tofts, W I McDonald, D H Miller, A J Thompson.   

Abstract

Recent MRI studies in multiple sclerosis have highlighted the potential importance of spinal cord atrophy (implicating axonal loss) in the development of disability. However, the techniques applied in these initial studies have poor reproducibility which limits their application in the serial monitoring of patients. The aim of this study was to develop a highly reproducible and accurate method for the quantification of atrophy. The technique we describe demonstrates an intra-observer coefficient of variation (scan-rescan) of only 0.8%. When applied to 60 patients with clinically definite multiple sclerosis there was a strong correlation between spinal cord area and disability measured by Kurtzke's Expanded Disability Status Scale (EDSS) (r = -0.7, P < 0.001). The correlation was graded providing evidence for a causal connection. At levels 3 and 8 of the EDSS we observed a reduction in average cord area of 12 and 35%, respectively. Given its reproducibility, the magnitude of the change detected and the strong correlation with disability, this new technique should prove to be a sensitive measure of progressive neurological deterioration and could be readily incorporated into imaging protocols aimed at monitoring therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8673483     DOI: 10.1093/brain/119.3.701

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  134 in total

1.  Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis.

Authors:  D B McGavern; P D Murray; C Rivera-Quiñones; J D Schmelzer; P A Low; M Rodriguez
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

Review 2.  Neurological rehabilitation: from mechanisms to management.

Authors:  A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-12       Impact factor: 10.154

Review 3.  Clinical trials and clinical practice in multiple sclerosis: conventional and emerging magnetic resonance imaging technologies.

Authors:  Massimo Filippi; Maria A Rocca; Marco Rovaris
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

Review 4.  MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials.

Authors:  Frederik Barkhof; Jack H Simon; Franz Fazekas; Marco Rovaris; Ludwig Kappos; Nicola de Stefano; Chris H Polman; John Petkau; Ernst W Radue; Maria P Sormani; David K Li; Paul O'Connor; Xavier Montalban; David H Miller; Massimo Filippi
Journal:  Nat Rev Neurol       Date:  2011-12-06       Impact factor: 42.937

5.  Spatial normalization and regional assessment of cord atrophy: voxel-based analysis of cervical cord 3D T1-weighted images.

Authors:  P Valsasina; M A Horsfield; M A Rocca; M Absinta; G Comi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2012-06-07       Impact factor: 3.825

6.  White and gray matter damage in primary progressive MS: The chicken or the egg?

Authors:  Benedetta Bodini; Declan Chard; Daniel R Altmann; Daniel Tozer; David H Miller; Alan J Thompson; Claudia Wheeler-Kingshott; Olga Ciccarelli
Journal:  Neurology       Date:  2015-12-16       Impact factor: 9.910

7.  Accurate quantification methods to evaluate cervical cord atrophy in multiple sclerosis patients.

Authors:  J Carbonell-Caballero; J V Manjón; L Martí-Bonmatí; J R Olalla; B Casanova; M de la Iglesia-Vayá; F Coret; M Robles
Journal:  MAGMA       Date:  2006-11-18       Impact factor: 2.310

8.  Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis.

Authors:  Carsten Lukas; Horst K Hahn; Barbara Bellenberg; Jan Rexilius; Gebhard Schmid; Sebastian K Schimrigk; Horst Przuntek; Odo Köster; Heinz-Otto Peitgen
Journal:  Neuroradiology       Date:  2004-11-05       Impact factor: 2.804

9.  2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.

Authors:  Nico Papinutto; Regina Schlaeger; Valentina Panara; Eduardo Caverzasi; Sinyeob Ahn; Kevin J Johnson; Alyssa H Zhu; William A Stern; Gerhard Laub; Stephen L Hauser; Roland G Henry
Journal:  J Magn Reson Imaging       Date:  2014-12-08       Impact factor: 4.813

10.  Axonal degeneration and progressive neurologic disability in multiple sclerosis.

Authors:  Carl Bjartmar; Bruce D Trapp
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.